18F-fluoromisonidazole (FMISO) is a positron emission tomography (PET) tracer that accumulates in hypoxic tissues. We here present a case of suspected cardiac sarcoidosis which was detected with increased FMISO uptake.
CITATION STYLE
Manabe, O., Hirata, K., Shozo, O., Shiga, T., Uchiyama, Y., Kobayashi, K., … Tamaki, N. (2017). 18F-fluoromisonidazole (FMISO) PET may have the potential to detect cardiac sarcoidosis. Journal of Nuclear Cardiology, 24(1), 329–331. https://doi.org/10.1007/s12350-016-0495-2
Mendeley helps you to discover research relevant for your work.